Serum-mediated enhancement of TNF-α release by human monocytes stimulated with the yeast form of Candida albicans

被引：33

作者：

Ghezzi, MC ^{[1
]}

Raponi, G ^{[1
]}

Angeletti, S ^{[1
]}

Mancini, C ^{[1
]}

机构：

[1] Univ Rome La Sapienza, Fac Med, Chair Clin Microbiol 1, I-00185 Rome, Italy

来源：

JOURNAL OF INFECTIOUS DISEASES | 1998年 / 178卷 / 06期

关键词：

D O I：

10.1086/314484

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

The role of serum in the production of tumor necrosis factor-alpha (TNF-alpha) by human monocytes stimulated with yeast-form Candida albicans was studied. Pre-exposure of C. albicans to human pooled serum enhanced both TNF-alpha mRNA and cytokine secretion compared with C, albicans preincubated with medium only. Serum factors involved were >30 kDa, were efficiently inhibited by D-mannose, and recognized both Ca++-dependent and -independent pathways, Preincubation of yeasts with rabbit mannose-binding protein (MBP) resulted in dose-related enhancement of TNF-alpha secretion, through a Ca++-dependent pathway inhibited by D-mannose, TNF-alpha levels were similarly induced in C. albicans preincubated with vitronectin and with serum. Ca++ depletion did not affect cytokine release, while D-mannose supplementation displayed inhibition. The latter effect was abolished after Ca++ depletion. These data call for an involvement of both MBP and vitronectin in the serum-mediated enhancement of TNF-alpha release upon stimulation of monocytes with yeast forms of C. albicans.

引用

页码：1743 / 1749

页数：7

共 35 条

[21] VITRONECTIN INTERACTS WITH CANDIDA-ALBICANS AND AUGMENTS ORGANISM ATTACHMENT TO THE NR8383 MACROPHAGE CELL-LINE [J].

LIMPER, AH ;

STANDING, JE .

IMMUNOLOGY LETTERS, 1994, 42 (03) :139-144

[22]

LIPSCOMBE RJ, 1995, IMMUNOLOGY, V85, P660

[23]

MALHOTRA R, 1994, IMMUNOLOGY, V82, P439

[24] MOLECULAR-CLONING AND EXPRESSION OF HUMAN-TUMOR NECROSIS FACTOR AND COMPARISON WITH MOUSE-TUMOR NECROSIS FACTOR [J].

MARMENOUT, A ;

FRANSEN, L ;

TAVERNIER, J ;

VANDERHEYDEN, J ;

TIZARD, R ;

KAWASHIMA, E ;

SHAW, A ;

JOHNSON, MJ ;

SEMON, D ;

MULLER, R ;

RUYSSCHAERT, MR ;

VANVLIET, A ;

FIERS, W .

EUROPEAN JOURNAL OF BIOCHEMISTRY, 1985, 152 (03) :515-522

[25]

MARODI L, 1991, J IMMUNOL, V146, P2783

[26]

MARODI L, 1994, J IMMUNOL, V153, P5643

[27] ACTIVATION OF THE CLASSICAL COMPLEMENT PATHWAY BY MANNOSE-BINDING PROTEIN IN ASSOCIATION WITH A NOVEL C1S-LIKE SERINE PROTEASE [J].

MATSUSHITA, M ;

FUJITA, T .

JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (06) :1497-1502

[28] A SIMPLE ONE-STEP PROCEDURE FOR PREPARATION OF C1-DEFICIENT HUMAN-SERUM [J].

NEOH, SH ;

GORDON, TP ;

ROBERTSTHOMSON, PJ .

JOURNAL OF IMMUNOLOGICAL METHODS, 1984, 69 (02) :277-280

[29] Fungal beta-glucan interacts with vitronectin and stimulates tumor necrosis factor alpha release from macrophages [J].

Olson, EJ ;

Standing, JE ;

GriegoHarper, N ;

Hoffman, OA ;

Limper, AH .

INFECTION AND IMMUNITY, 1996, 64 (09) :3548-3554

[30] TUMOR-NECROSIS-FACTOR-ALPHA (TNF-ALPHA) PRODUCTION IN MICE IMMUNIZED WITH ESCHERICHIA-COLI - CORRELATION WITH MORTALITY AFTER LETHAL CHALLENGE AND PRODUCTION OF A NATIVE INHIBITOR OF TNF-ALPHA ACTIVITY [J].

RAPONI, G ;

KELLER, N ;

ROZENBERGARSKA, M ;

LUN, MT ;

MANCINI, C ;

VERHOEF, J .

INFECTION AND IMMUNITY, 1993, 61 (09) :3976-3980

← 1 2 3 4 →